Normocain (Articaine Hydrochloride, Epinephrine)

Articaine, the active component of Normocain, blocks voltage‑gated sodium channels on nerve cells, preventing the generation and transmission of pain signals. The accompanying epinephrine causes local blood‑vessel constriction, extending the anesthetic effect and reducing bleeding.

The appropriate dose of Normocain is determined by the prescribing dentist or oral surgeon based on the specific procedure, patient age, weight, and medical history. Dosage decisions are individualized and should follow professional clinical guidelines.

The safety of Normocain in pregnancy or while breastfeeding has not been definitively established. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and after consulting a healthcare professional.

To order Normocain, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Normocain (articaine) is an amide‑type local anesthetic with a relatively rapid onset and good tissue penetration compared with older agents like lidocaine. Its formulation with epinephrine also offers prolonged anesthesia and reduced intra‑operative bleeding, making it a preferred choice for many dental clinicians.

Normocain should be stored at ambient temperature, below 25 °C, in its original container. Protect the product from direct light and moisture to maintain potency. Do not freeze or expose it to extreme temperatures.

Normocain is administered by a dental professional via intra‑oral injection. The solution is deposited in the soft tissue near the target tooth or area, allowing the anesthetic to diffuse and achieve localized numbness for the duration of the procedure.

Serious risks include allergic reactions that may progress to anaphylaxis, cardiovascular events such as arrhythmia or hypertension due to epinephrine, methemoglobinemia, and prolonged or unexpected numbness. Immediate medical attention is required if any severe symptoms develop.

Normocain should be avoided in patients with known hypersensitivity to articaine, other amide‑type anesthetics, or epinephrine. It is also contraindicated in individuals with severe cardiac disease, uncontrolled hypertension, hyperthyroidism, or certain metabolic disorders unless a clinician determines that benefits outweigh risks.